← Home

Euronext Paris · PA

Boiron SA

Consensus (WSTP)
Moving averages
With dividends

BOI · boiron-sa-pa

Last close
25,2
Currency
EUR
ISIN
FR0000061129

Stock metrics

Historical DR %
7,2
Volatility
48,92
DR distance (σ)
-1,5
5y performance
20,81
10y performance
13,8

Company

Industry
Pharmaceuticals
Market cap
486
Beta
0,25
Operating quality
3
Potential quality
3
WSTP
25
WSTP perf. / last close
-0,8
Dividend
1,2
Dividend yield
4,76
Last close / book value
1,19
Last close / revenue per share
0,87
PEG ratio
0

Trend

20252026
bnpa1,562,06
per1612
croissance32.1%

Boiron SA est une entreprise pharmaceutique française spécialisée dans les médicaments homéopathiques. Fondée en 1932 par les frères Jean et Henri Boiron, la société est devenue un leader mondial dans le domaine de l'homéopathie. Basée à Lyon, Boiron produit et distribue une large gamme de produits homéopathiques destinés à traiter diverses affections. La société est connue pour ses marques emblématiques comme Oscillococcinum et Arnicare. Avec une présence dans plus de 50 pays, Boiron s'engage à promouvoir la santé naturelle et à offrir des solutions thérapeutiques alternatives. L'entreprise met un point d'honneur à respecter des normes de qualité rigoureuses et à innover constamment pour répondre aux besoins des patients.

Company financials

Absolute amounts (revenue, operating result, net income, equity, cash flow) are in whole millions (÷ 10⁶, rounded).

Revenue and margins over 20 years

Revenue Operating margin Net margin
01002003004005006000%5%10%15%20%2005 - Revenue: 3622006 - Revenue: 3992007 - Revenue: 4342008 - Revenue: 4672009 - Revenue: 5262010 - Revenue: 5212011 - Revenue: 5232012 - Revenue: 5662013 - Revenue: 6182014 - Revenue: 6102015 - Revenue: 6082016 - Revenue: 6142017 - Revenue: 6182018 - Revenue: 6042019 - Revenue: 5572020 - Revenue: 5142021 - Revenue: 4552022 - Revenue: 5342023 - Revenue: 4932024 - Revenue: 4882005 - Operating margin: 6,8%2006 - Operating margin: 4,8%2007 - Operating margin: 10,3%2008 - Operating margin: 12,2%2009 - Operating margin: 17,4%2010 - Operating margin: 12,8%2011 - Operating margin: 12,2%2012 - Operating margin: 14,3%2013 - Operating margin: 23,6%2014 - Operating margin: 24,0%2015 - Operating margin: 22,2%2016 - Operating margin: 21,8%2017 - Operating margin: 21,1%2018 - Operating margin: 17,9%2019 - Operating margin: 13,0%2020 - Operating margin: 7,4%2021 - Operating margin: 8,2%2022 - Operating margin: 10,5%2023 - Operating margin: 8,6%2024 - Operating margin: 3,2%2005 - Net margin: 4,5%2006 - Net margin: 2,6%2007 - Net margin: 6,3%2008 - Net margin: 8,4%2009 - Net margin: 11,4%2010 - Net margin: 8,3%2011 - Net margin: 8,1%2012 - Net margin: 8,8%2013 - Net margin: 13,3%2014 - Net margin: 14,6%2015 - Net margin: 12,2%2016 - Net margin: 12,6%2017 - Net margin: 12,7%2018 - Net margin: 9,5%2019 - Net margin: 7,3%2020 - Net margin: 5,1%2021 - Net margin: 6,3%2022 - Net margin: 8,4%2023 - Net margin: 7,3%2024 - Net margin: 2,3%20052006200720082009201020112012201320142015201620172018201920202021202220232024M%

Over the last 10 years, revenue decreased by an average of -2.2% per year, with 7 year(s) of decline over the period.

Earnings per share (EPS) decreased by an average of -17.9% per year, with 6 year(s) of decline over the period.

Over the last 10 years, return on equity averaged 10.0%.

It broadly declined over the period, from 23.5% 10 years ago to 3.0% in 2024.

The Equity / Total balance sheet ratio was 66% in 2024: the balance sheet is solid.

The Equity / Total balance sheet ratio broadly increased over the period: it was 57% 10 years ago.

AverageCAGR20142015201620172018201920202021202220232024
Revenue-2,2%610608614618604557514455534493488
Revenue growth-1,3%-0,33%1,07%0,5%-2,16%-7,79%-7,82%-11,37%17,36%-7,67%-1,15%
Operating result-20,0%146135134130108723837564216
Operating margin13,4%24,0%22,2%21,8%21,1%17,9%13,0%7,4%8,2%10,5%8,6%3,2%
Net income-18,6%8974787857412629453611
Net margin8,4%14,6%12,2%12,6%12,7%9,5%7,3%5,1%6,3%8,4%7,3%2,3%
Earnings per share (EPS)-17,9%4,664,014,224,253,282,321,51,632,572,060,65
EPS growth9,9%-13,9%5,2%0,7%-22,8%-29,3%-35,3%8,7%57,7%-19,8%-68,4%
Equity-0,0%380416470517486505509532558394378
Return on equity10,0%23,5%17,8%16,6%15,1%11,8%8,0%5,1%5,4%8,0%9,1%3,0%
Equity / Total balance sheet (%)57%60%62%65%63%66%65%69%71%67%66%
Operating cash flow9610311010584516833594540
Cash flow growth-10,1%7,3%6,8%-4,9%-19,6%-39,6%34,2%-51,2%76,2%-22,5%-13,1%